Ampio Pharmaceuticals, Inc. (AMPE)

NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
0.163
-0.009 (-4.96%)
At close: May 25, 2022 4:00 PM
0.155
-0.008 (-5.092%)
After-hours:May 25, 2022 7:34 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20212020201920182017201620152014201320122011 - 2007
Revenue
000000000.050.05
Upgrade
Revenue Growth (YoY)
--------0.00%-
Upgrade
Gross Profit
000000000.050.05
Upgrade
Selling, General & Admin
8.676.665.954.365.266.549.068.967.485.83
Upgrade
Research & Development
11.99.1712.626.8310.4210.5515.1122.4916.66.04
Upgrade
Operating Expenses
20.5715.8318.5811.1815.6817.0824.1731.4524.0711.87
Upgrade
Operating Income
-20.57-15.83-18.58-11.18-15.68-17.08-24.17-31.45-24.02-11.82
Upgrade
Interest Expense / Income
0000.01-0000-0.010
Upgrade
Other Expense / Income
-3.50.06-4.95-45.1836.222.08-0.06-0.14-0-0.23
Upgrade
Pretax Income
-17.08-15.89-13.6333.99-51.89-19.16-24.11-31.31-24.01-11.59
Upgrade
Net Income
-17.08-15.89-13.6333.99-51.89-19.16-24.11-31.31-24.01-11.59
Upgrade
Net Income Common
-17.08-15.89-13.6333.99-51.89-19.16-24.11-31.31-24.01-11.59
Upgrade
Shares Outstanding (Basic)
19917313173655452503834
Upgrade
Shares Outstanding (Diluted)
20517313191655452503834
Upgrade
Shares Change
18.58%31.81%43.96%39.50%21.43%3.43%3.52%31.16%12.68%-
Upgrade
EPS (Basic)
-0.09-0.09-0.100.46-0.79-0.36-0.62-0.76-0.63-0.34
Upgrade
EPS (Diluted)
-0.10-0.09-0.14-0.12-0.79-0.36-0.62-0.76-0.63-0.34
Upgrade
Free Cash Flow Per Share
-0.07-0.09-0.12-0.17-0.18-0.27-0.51-0.79-0.53-0.29
Upgrade
Gross Margin
--------100.00%100.00%
Upgrade
Operating Margin
---------48047.75%-23641.51%
Upgrade
Profit Margin
---------48017.12%-23186.09%
Upgrade
Free Cash Flow Margin
---------40889.08%-19430.33%
Upgrade
EBITDA
-15.98-14.72-12.3635.27-50.68-17.95-23.28-30.96-23.88-11.53
Upgrade
EBITDA Margin
---------47766.33%-23061.30%
Upgrade
EBIT
-17.08-15.89-13.6333.99-51.9-19.16-24.11-31.31-24.02-11.59
Upgrade
EBIT Margin
---------48041.69%-23186.09%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).